Endo International PLC (ENDP) News
Filter ENDP News Items
ENDP News Results
|Loading, please wait...|
ENDP News Highlights
- For ENDP, its 30 day story count is now at 16.
- Over the past 22 days, the trend for ENDP's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- AL, BEAT and CNVY are the most mentioned tickers in articles about ENDP.
Latest ENDP News From Around the Web
Below are the latest news stories about Endo International plc that investors may wish to consider to help them evaluate ENDP as an investment opportunity.
Endo's (ENDP) fourth-quarter earnings might have gained from higher sales of Xiaflex.
Endo (ENDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Endo International (ENDP) closed at $3.08 in the latest trading session, marking a -0.65% move from the prior day.
FORT LAUDERDALE, Fla. , Feb. 15, 2022 /PRNewswire/ -- Convey Health Solutions Holdings, Inc. (NYSE: CNVY ) ("Convey"), a leading healthcare technology and services company, today announced the appointment of Paul Campanelli to its Board of Directors ("Board"). Mr. Campanelli has approximately 30 years of experience in the healthcare industry, including leadership positions in both publicly held and private equity controlled companies. Mr. Campanelli previously served as Chairman of the Board of Endo International ("Endo") from November 2019 to June 2021 , and previously served as President and Chief Executive Officer of Endo from September 2016 to March 2020 . While acting as Chief Executive Officer, Mr. Campanelli focused on executing Endo''s strategy to improve productivity, simplify ...
Miller Value Partners, an investment management firm, published its Miller Deep Value Strategy fourth quarter 2021 investor letter a copy of which can be seen here.
DUBLIN ,, Feb. 11, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it expects a Tennessee state court to issue an order granting plaintiffs'' request for a default judgment on liability against Endo''s wholly-owned subsidiaries Endo Health Solutions Inc. and Endo
Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
In the latest trading session, Endo International (ENDP) closed at $3.14, marking a +1.95% move from the previous day.
First and only manufacturer-prepared, FDA approved vasopressin in a premixed ready-to-use (RTU) format
Endo International (ENDP) closed at $3.21 in the latest trading session, marking a +0.63% move from the prior day.